Press release 2019-12-05- New study shows that Mollii reduces chronic pain
A new study by MD Riachi and co-workers, has shown that Mollii significantly reduces pain in patients with fibromyalgia and other pain-related disorders.
The study, which was presented at the World Congress of Neurology in Dubai last month, aimed to investigate the effects of the Mollii suit on chronic pain. 200 patients with fibromyalgia, Parkinson’s disease and various other pain-associated conditions were included. The patients wore the electrostimulation suit for one hour and the pain levels were compared before, immediately after and 24 hours after, using a Visual Analogue Scale (VAS). The results from the study showed a significant reduction of perceived pain immediately after the intervention and the effect was partially still present 24 hours later.
Read poster abstract here.
Study title: Pain Reducing Properties of the Mollii Suit on Adults with Chronic pain syndromes
Naji Riachi1, G. Khazen1, R. Ahdab1, S. Jörgen2
1 Lebanese American University School of Medicine, Neurology, Beirut, Lebanon
2 Metier Medical, Clinical Director, Cessnock, Australia
World Congress of Neurology, Dubai, October 27-31, 2019.
For further information please contact:
Mimi Westerlund, Chief Research Officer
Telephone: +46 8-410 277 01
Email: mimi.westerlund@inerventions.se
Inerventions is a Stockholm-based company that helps people to a life in motion. The company has developed the product Mollii, which is used by people with neurological injuries and diseases such as CP, acquired brain injury, spinal cord injury, Stroke and MS.